REGN Today - Aug 07: New Investments and Class Action

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

REGN Today - Aug 07: New Investments and Class Action

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey, your friendly stock enthusiast, here to break down today’s moves. Today, we’re talking about Regeneron Pharmaceuticals, and it was a bit of a mixed bag. The stock was up just a smidge, barely moving at 0.51%.

So, what went down? Well, the trading volume was pretty steady, which is kinda normal for REGN. A couple of investment firms made some headlines today. Assenagon Asset Management scooped up over 37,000 shares, which is a nice little vote of confidence. And Segall Bryant & Hamill also jumped in with a fresh investment of a million bucks. Always nice to see folks putting their money where their mouth is, right?

But here’s the kicker. There’s some chatter about a class action lawsuit for investors who lost money on REGN. Yeah, that one stung for a lot of people. It’s always a bit of a red flag when lawsuits start popping up, and I’m sure it’s got people talking.

Now, why did the stock barely budge despite some positive vibes from those investments? Honestly, nobody really knows. Sometimes the market just decides to be chill, even when there’s a mix of good and bad news floating around.

On the horizon, Barclays is sticking with their buy rating on Regeneron, which could give some folks a little boost of confidence. Ratings can play a big role in how investors feel, so that’s worth keeping an eye on.

Alright, that’s the scoop for today! Just remember, I’m here to share info and keep it fun, not to give any financial advice. Catch you later!

まだレビューはありません